Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

15.77 +0.17 (+1.09%)
Streaming Delayed Price Updated: 10:13 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 15 companies hit new 52-week lows. 
Via Benzinga
News headline image
Recap: Orthofix Medical Q1 Earnings ↗
Orthofix Medical (NASDAQ:OFIX) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
News headline image
Recap: Orthofix Medical Q2 Earnings ↗
  Orthofix Medical (NASDAQ:OFIX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Orthofix Reports Second Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 5, 2022 ↗
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. 
Via Benzinga
News headline image
Orthofix Medical Earnings Preview ↗
Orthofix Medical (NASDAQ:OFIX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Orthofix... 
Via Benzinga
News headline image
Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market
From Orthofix Medical Inc.
Via Business Wire
News headline image
Looking Into Orthofix Medical's Return On Invested Capital ↗
According to Benzinga Pro data, during Q1, Orthofix Medical (NASDAQ:OFIX) posted sales of $106.42 million. Earnings were up 86.41%, but Orthofix Medical still reported an overall loss of $4.46... 
Via Benzinga
News headline image
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports First Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Outlook For Orthofix Medical ↗
Orthofix Medical (NASDAQ:OFIX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Orthofix... 
Via Benzinga
News headline image
FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 6, 2022 ↗
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion. 
Via Benzinga
News headline image
Orthofix and MTF Biologics Expand Partnership Agreement
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical Q1 2022 Earnings Conference Call On May 6, 2022 At 08:30 AM ET ↗
Orthofix Medical (NASDAQ:OFIX) will host a conference call at 08:30 AM ET on May 6, 2022, to discuss Q1 2022 earnings results. How to Attend Orthofix Medical (OFIX) Conference Call Follow this link to... 
Via Benzinga
News headline image
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces New Business Unit President
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022 ↗
Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the... 
Via Benzinga
News headline image
Orthofix Medical Earnings Perspective: Return On Capital Employed ↗
Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q4 sales of $125.06 million. Earnings fell to a loss of $32.81 million, resulting in a 1411.38% decrease from last... 
Via Benzinga
News headline image
Recap: Orthofix Medical Q4 Earnings ↗
Orthofix Medical (NASDAQ:OFIX) reported its Q4 earnings results on Friday, February 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For February 25, 2022 ↗
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.